Amorphous organic-hybrid vanadium oxide for near-barrier-free ultrafast-charging aqueous zinc-ion battery.

Fast-charging metal-ion batteries are essential for advancing energy storage technologies, but their performance is often limited by the high activation energy (E) required for ion diffusion in solids. Addressing this challenge has been particularly difficult for multivalent ions like Zn. Here, we present an amorphous organic-hybrid vanadium oxide (AOH-VO), featuring one-dimensional chains arranged in a disordered structure with atomic/molecular-level pores for promoting hierarchical ion diffusion pathways and reducing Zn interactions with the solid skeleton.

Coffee and tea consumption and glioma risk: a meta-analysis of cohort studies.

Background: Research on the association between glioma risk and coffee and tea consumption remains inconclusive. This study seeks to present a meta-analysis of the relationship between coffee and tea intake and glioma risk.

Method: Relevant cohort studies that collected coffee and tea exposure prospectively were identified through searches of the PubMed, Embase, and Scopus databases.

Recent advances in developing targeted protein degraders.

Targeted protein degradation (TPD) represents a promising therapeutic approach, encompassing several innovative strategies, including but not limited to proteolysis targeting chimeras (PROTACs), molecular glues, hydrophobic tag tethering degraders (HyTTD), and lysosome-targeted chimeras (LYTACs). Central to TPD are small molecule ligands, which play a critical role in mediating the degradation of target proteins. This review summarizes the current landscape of small molecule ligands for TPD molecules.

Clinical characteristics, etiology, and treatment of young adult-onset epilepsy: A 24-year retrospective study.

Objective: To analyze the clinical characteristics, etiology, drug treatment, and related factors of patients with young adult-onset epilepsy.

Methods: The study included patients with epilepsy aged between 18 and 44 years and aimed to analyze the clinical characteristics of epilepsy in young people and their response to antiseizure medication (ASM) over a 24-year period (February 1999 and March 2023).

Results: A total of 4227 patients experienced epilepsy onset between 18 and 44 years of age.

The combination of decitabine with multi-omics confirms the regulatory pattern of the correlation between DNA methylation of the CACNA1C gene and atrial fibrillation.

Background: Studies have shown that DNA methylation of the CACNA1C gene is involved in the pathogenesis of various diseases and the mechanism of drug action. However, its relationship with atrial fibrillation (AF) remains largely unexplored.

Objective: To investigate the association between DNA methylation of the CACNA1C gene and AF by combining decitabine (5-Aza-2'-deoxycytidine, AZA) treatment with multi-omics analysis.